Tonoderm NF cream full describe

Searching the Web

Tonoderm NF cream composition uses dosage side effects

Searching the Web

Tonoderm NF cream ingredients mechanism of action prescribing information

Searching the Web

Tonoderm NF cream manufacturer India composition neomycin fluocinolone

Based on my research, here is a complete description of Tonoderm NF Cream:

Tonoderm NF Cream - Full Description

Note: "Tonoderm NF" is the brand name. Its widely marketed equivalent/same-composition product is Tocoderm NF+ by Cipla Ltd (one of India's largest pharma companies). The "NF" stands for Neomycin + Fluocinolone or similar combination depending on the specific variant. There is also a "Tonoderm 5%" variant with a different 5-ingredient formula (by Metrocraft).

Composition

Tonoderm NF / Tocoderm NF+ (Standard - Cipla)

Active IngredientConcentrationDrug Class
Clobetasol Propionate0.05% w/wCorticosteroid (Class I - Super potent)
Miconazole Nitrate2.0% w/wAntifungal (Azole)
Neomycin Sulphate0.1% w/wAntibiotic (Aminoglycoside)

Tonoderm 5% Cream (Metrocraft variant)

Active IngredientConcentration
Clobetasol Propionatepresent
Ketoconazolepresent
Neomycin Sulphatepresent
Tolnaftatepresent
Iodochlorhydroxyquinoline (Clioquinol)present

Mechanism of Action

1. Clobetasol Propionate (Corticosteroid)

  • Binds to intracellular glucocorticoid receptors
  • Blocks production of inflammatory chemical messengers (prostaglandins, leukotrienes, cytokines)
  • Reduces redness, swelling, itching, and skin inflammation
  • Suppresses immune-mediated skin reactions

2. Miconazole Nitrate (Antifungal)

  • Belongs to the azole class
  • Inhibits fungal cytochrome P450 enzyme 14-alpha-demethylase
  • Prevents conversion of lanosterol to ergosterol (an essential fungal cell membrane component)
  • Disrupts fungal cell membrane integrity, leading to cell death
  • Effective against dermatophytes, Candida species, and some gram-positive bacteria

3. Neomycin Sulphate (Antibiotic)

  • Aminoglycoside antibiotic
  • Binds to the 30S ribosomal subunit of bacteria
  • Inhibits bacterial protein synthesis
  • Effective against gram-negative bacteria and some gram-positive organisms
  • Prevents secondary bacterial infection and superinfection

Therapeutic Uses (Indications)

  • Infected eczema / dermatitis - with secondary bacterial or fungal infection
  • Tinea infections - Tinea corporis (ringworm), Tinea cruris (jock itch), Tinea pedis (athlete's foot)
  • Cutaneous candidiasis - yeast infection of the skin
  • Seborrheic dermatitis - with inflammation, scaling, and redness
  • Psoriasis - when complicated by infection
  • Intertrigo - skin fold infections
  • Infected napkin rash / diaper dermatitis
  • Otitis externa - outer ear infections (when prescribed in appropriate form)
  • Mixed bacterial-fungal skin infections with underlying inflammation

Dosage and Administration

  • Route: Topical (external use only)
  • Application: Apply a thin layer to the affected area(s)
  • Frequency: Typically 2 times daily (morning and evening) or as directed by your doctor
  • Duration: Usually not more than 2-4 weeks continuously (due to the potent steroid content)
  • Method:
    • Clean and dry the affected area thoroughly before application
    • Apply with clean, dry hands
    • Gently rub in until absorbed
    • Do not bandage or occlude the area tightly unless specifically instructed
    • Wash hands after application

Side Effects

Common (Local/Application Site)

  • Burning or stinging sensation at the application site
  • Skin irritation and redness
  • Itching
  • Dryness and peeling

Prolonged Use - Steroid-Related Effects

  • Skin thinning (atrophy) - particularly on delicate areas
  • Striae (stretch marks)
  • Telangiectasia (visible small blood vessels)
  • Hypopigmentation (skin lightening)
  • Acne / Perioral dermatitis
  • Hypertrichosis (increased hair growth)
  • Contact dermatitis (paradoxical reaction)

Systemic (Rare, with extensive/prolonged use)

  • HPA axis suppression - adrenal insufficiency from absorbed clobetasol
  • Cushing's syndrome features with very extensive application
  • Neomycin ototoxicity (hearing loss) - rare with topical use but possible if used on large areas or broken skin
  • Nephrotoxicity - rare

Allergic Reactions

  • Rash, urticaria (hives), swelling, shortness of breath
  • Neomycin is a well-known contact allergen - sensitization can occur with prolonged use

Contraindications

  • Known hypersensitivity to clobetasol, miconazole, neomycin, or any component
  • Viral skin infections - herpes simplex, chickenpox, shingles (corticosteroids worsen these)
  • Tuberculosis of the skin
  • Rosacea and perioral dermatitis
  • Acne vulgaris
  • Open wounds or broken/ulcerated skin
  • Periocular region (around the eyes - risk of glaucoma and cataracts)
  • Do not use as a long-term treatment without medical supervision

Precautions and Warnings

CategoryAdvice
PregnancyUse with caution; avoid on large areas or for prolonged periods. Consult your doctor.
BreastfeedingAvoid applying to the breast or surrounding area. Consult doctor.
ChildrenUse only under strict medical supervision. Avoid use in children under 1 year. Children are more prone to systemic absorption.
ElderlySkin thinning risk is higher; use minimum effective amount.
Face/Skin foldsAvoid use on the face, groin, and axillae (enhanced absorption) unless specifically directed.
Ophthalmic useAvoid contact with eyes - risk of glaucoma and cataracts.
Long-term useDo not use continuously beyond 2-4 weeks without re-evaluation.
Kidney diseaseUse with caution; neomycin has nephrotoxic potential.

Drug Interactions

  • Other topical corticosteroids - additive suppression of HPA axis
  • Immunosuppressants - increased risk of systemic effects
  • Neomycin may potentiate the ototoxic/nephrotoxic effects of systemic aminoglycosides if absorbed

Storage

  • Store below 30°C
  • Keep away from direct sunlight and moisture
  • Keep out of reach of children
  • Do not freeze

How Supplied / Availability

  • Pack size: 15 g tube (most common)
  • Prescription status: Requires a valid prescription (Schedule H drug in India)
  • Manufacturer (Tocoderm NF): Cipla Ltd, Mumbai
  • Tonoderm 5%: Metrocraft Pharmaceuticals

Key Clinical Points

  1. This is a triple-combination (steroid + antifungal + antibiotic) cream designed for mixed infections - do not use it as a standalone antifungal or antibiotic.
  2. The potent steroid (clobetasol) limits how long it can be safely used - typically 2 weeks maximum on sensitive areas.
  3. Neomycin sensitivity is common; if itching worsens after initial improvement, suspect contact sensitization.
  4. Not suitable as a skin-lightening cream, though it is sometimes misused for this purpose - this leads to steroid-induced skin damage.
  5. Always confirm the diagnosis before starting - using a steroid over an unrecognized fungal or viral infection can worsen it.

This information is for educational purposes. Always follow your prescribing physician's instructions regarding dosage and duration.

Ketoconazole, iodochorhydroxyquinoline,tolnaftate,gentamicin,clobetasol proprionate cream full describe

Reading File
Searching the Web

ketoconazole iodochlorhydroxyquinoline tolnaftate gentamicin clobetasol cream combination brand India uses

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Searching the Web

Dermicube Dermi5 pentaderm ketoconazole iodochlorhydroxyquinoline tolnaftate gentamicin clobetasol cream complete prescribing info

I now have comprehensive information from authoritative textbook sources (Fitzpatrick's Dermatology, Katzung Pharmacology, Andrews' Diseases of the Skin, Goodman & Gilman) plus verified drug database sources. Here is the full description:

Ketoconazole + Iodochlorhydroxyquinoline + Tolnaftate + Gentamicin + Clobetasol Propionate Cream

Full Description

This is a broad-spectrum, penta-combination topical cream that simultaneously targets bacterial infection, fungal infection, and skin inflammation. It is widely marketed in India under brand names such as Dermicube, Dermiact, Dermipan, Ketohext Plus, Ketonage-Plus, Dermitek, D-Derm KT, K2-Tone, and others.

Composition (Typical Strengths)

IngredientTypical ConcentrationDrug Class
Clobetasol Propionate0.05% w/wSuper-potent corticosteroid (Class I)
Ketoconazole2.0% w/wAzole antifungal
Iodochlorhydroxyquinoline (Clioquinol)1.0% w/wHalogenated quinoline antimicrobial
Tolnaftate1.0% w/wThiocarbamate antifungal
Gentamicin Sulphate0.1% w/wAminoglycoside antibiotic
Pack size: 15 g tube | Route: Topical only | Prescription required (Schedule H)

Mechanism of Action - Each Ingredient

1. Clobetasol Propionate (0.05%) - Super-Potent Corticosteroid

  • Binds cytosolic glucocorticoid receptors, translocates to the nucleus
  • Suppresses transcription of pro-inflammatory genes (phospholipase A2 inhibition via lipocortin)
  • Blocks prostaglandins, leukotrienes, histamine, cytokines - reducing redness, swelling, itching, and skin inflammation
  • Class I (super-potent) steroid - the strongest category of topical corticosteroid
  • Anti-proliferative action reduces epidermal cell turnover in conditions like psoriasis
  • Source: Lippincott Pharmacology; Andrews' Diseases of the Skin

2. Ketoconazole (2%) - Azole Antifungal

  • Inhibits fungal cytochrome P450 14α-demethylase enzyme
  • Blocks conversion of lanosterol → ergosterol (essential fungal cell membrane sterol)
  • Disrupts fungal membrane integrity and permeability, leading to cell death
  • Fungicidal at high concentrations; fungistatic at lower levels
  • Additional anti-inflammatory activity has been postulated for topical formulations
  • Effective against: dermatophytes (Tinea spp.), Candida spp., Malassezia (Pityrosporum)
  • Systemic absorption of topical ketoconazole is negligible
  • Source: Fitzpatrick's Dermatology, Vol. 1-2

3. Iodochlorhydroxyquinoline / Clioquinol (1%) - Halogenated Quinoline

  • Broad-spectrum antimicrobial with both antibacterial and antifungal activity
  • Mechanism: chelates metal ions (particularly zinc and iron) essential for microbial enzyme function
  • Disrupts cell membrane integrity and inhibits vital enzyme systems in both bacteria and fungi
  • Active against gram-positive bacteria, some gram-negative bacteria, and fungi (including Candida)
  • Provides an additional layer of coverage against bacteria not covered by gentamicin alone
  • Releases iodine and chlorine ions that have direct antimicrobial activity

4. Tolnaftate (1%) - Thiocarbamate Antifungal

  • Inhibits squalene epoxidase enzyme in fungi (same enzyme targeted by terbinafine)
  • Blocks the conversion of squalene to lanosterol, disrupting ergosterol synthesis
  • Leads to accumulation of squalene in the fungal cell, which is toxic
  • Effective against dermatophytes: Epidermophyton, Microsporum, Trichophyton spp.
  • Also active against Malassezia (Pityriasis versicolor)
  • Not effective against Candida - this is why ketoconazole is also included
  • Generally well tolerated; rarely causes irritation or allergic contact dermatitis
  • Available as cream, powder, solution, aerosol; used twice daily for 2-4 weeks
  • Source: Katzung's Basic & Clinical Pharmacology, 16th Edition; Jawetz Microbiology

5. Gentamicin Sulphate (0.1%) - Aminoglycoside Antibiotic

  • Binds irreversibly to the 30S ribosomal subunit (specifically 16S rRNA)
  • Causes misreading of mRNA codons → incorporates wrong amino acids → faulty proteins
  • Also disrupts bacterial cell membrane integrity by direct binding
  • Requires oxygen-dependent active transport into bacterial cell (therefore ineffective against strict anaerobes)
  • Spectrum: Broad-spectrum gram-negative coverage (Pseudomonas, E. coli, Klebsiella, Proteus) and some gram-positive (Staphylococcus aureus)
  • Topical gentamicin is used for infected skin lesions including impetigo and secondarily infected wounds
  • Source: Goodman & Gilman; Medical Microbiology

Therapeutic Uses (Indications)

ConditionRationale
Tinea corporis (Ringworm)Ketoconazole + Tolnaftate target dermatophytes; Clobetasol reduces itch/inflammation
Tinea cruris (Jock itch)Dual antifungal coverage; Clobetasol reduces erythema
Tinea pedis (Athlete's foot)Dermatophyte coverage + antibacterial for secondary infection
Tinea versicolorKetoconazole targets Malassezia species
Cutaneous candidiasisKetoconazole provides azole coverage for Candida
Infected eczema / Atopic dermatitisClobetasol controls inflammation; Gentamicin + Clioquinol cover bacterial superinfection
Secondarily infected psoriasisAnti-inflammatory + antimicrobial coverage
Intertrigo (Skin fold infections)Mixed bacterial-fungal infections in warm, moist skin folds
Infected contact dermatitisAddresses both inflammation and secondary infection
Seborrheic dermatitis with secondary infectionKetoconazole targets Malassezia; steroid reduces scaling/inflammation
Napkin/diaper dermatitis (secondary infection)Combined coverage with caution

Dosage and Administration

  • Route: External/Topical use only
  • Method: Apply a thin layer to the affected area(s) with clean, dry hands
  • Frequency: Usually twice daily (morning and evening), or as directed by the prescriber
  • Duration: Typically 2-4 weeks maximum - limit use due to the potent steroid content
  • Clean and dry the affected area before application
  • Avoid occlusive dressings unless specifically instructed by the doctor
  • Wash hands after applying (unless hands are the affected area)

Side Effects

Local / Application Site (Common)

  • Burning and stinging at application site
  • Erythema (redness) and irritation
  • Itching (paradoxical)
  • Skin peeling and dryness

Corticosteroid-Related (with Prolonged Use) - Andrews' Diseases of the Skin

  • Skin atrophy - thinning, fragility, purpura
  • Striae distensae (stretch marks, irreversible)
  • Telangiectasia - visible small blood vessels, especially on the face
  • Hypopigmentation - skin lightening at application site
  • Hypertrichosis - local increased hair growth
  • Perioral dermatitis / Steroid rosacea - especially with facial use
  • Acneiform eruption - steroid acne
  • "Steroid addiction" - severe rebound on stopping, especially on face/genitalia
  • Tachyphylaxis - reduced efficacy with continued use
  • HPA axis suppression - if used over large areas; risk of Addisonian crisis and Cushing syndrome; growth retardation in children (>50% BSA)

Gentamicin-Related

  • Contact sensitization - allergic contact dermatitis
  • Ototoxicity (hearing loss) - rare, with extensive topical use on large wounds/burns
  • Nephrotoxicity - rare with topical use

Ketoconazole-Related (Topical - Rare)

  • Itching, contact dermatitis, allergic reactions
  • Minimal systemic absorption from topical use

Clioquinol (Iodochlorhydroxyquinoline)-Related

  • Yellow/brown staining of skin, nails, and clothing
  • Mild irritation
  • May give false-positive PBI (protein-bound iodine) test results due to iodine content
  • Rarely, systemic absorption can cause subacute myelo-optic neuropathy (SMON) - only with very extensive/prolonged use

Contraindications

  • Known allergy/hypersensitivity to any of the five active ingredients
  • Viral skin infections - herpes simplex, varicella zoster, molluscum contagiosum (steroid worsens these)
  • Tuberculosis of the skin (lupus vulgaris)
  • Rosacea and perioral dermatitis (steroid aggravates)
  • Acne vulgaris (steroid acne risk)
  • Perianal and genital use without strict specialist supervision - high absorption, atrophy risk
  • Ophthalmic use (near or in the eyes) - risk of steroid-induced glaucoma and cataracts
  • Open wounds, ulcers, or burns - systemic absorption risk
  • Do not use as a skin-lightening cream (common misuse in India)

Precautions

Patient GroupGuidance
PregnancyAvoid on large areas for prolonged periods. Consult doctor. Category C risk.
BreastfeedingDo not apply on the breast or near it. Use minimum amount.
ChildrenUse with extreme caution. Children have higher surface area-to-body weight ratio → greater systemic absorption. Do not use in infants.
ElderlyHigher skin atrophy risk. Use minimum effective amount for shortest duration.
Face/skin foldsAbsorption greatly enhanced. Avoid unless specifically directed.
Large BSA applicationRisk of HPA axis suppression, Cushing syndrome.
Kidney diseaseCaution - gentamicin may accumulate if absorbed.
Thyroid testsClioquinol can interfere with iodine-based thyroid tests.

Drug Interactions

Interacting DrugEffect
Other topical steroidsAdditive HPA axis suppression
Systemic corticosteroidsCombined systemic load - Cushing risk
Systemic aminoglycosides (IV Gentamicin)Additive ototoxicity and nephrotoxicity if absorbed
Ketoconazole + systemic CYP3A4 substratesNegligible with topical ketoconazole (minimal systemic absorption)
ImmunosuppressantsIncreased risk of opportunistic infection under the occlusion site

Storage

  • Store below 25-30°C (room temperature)
  • Protect from direct sunlight and heat
  • Do not freeze
  • Keep tube tightly closed
  • Keep out of reach of children

Key Clinical Points

  1. Not for skin lightening - a very common misuse in India that leads to steroid-induced skin damage (atrophy, telangiectasia, fungal overgrowth, steroid dependence).
  2. Dual antifungal coverage (Ketoconazole + Tolnaftate) ensures coverage for both azole-sensitive fungi AND dermatophytes; Tolnaftate fills the gap where azoles may be less effective.
  3. Clioquinol complements Gentamicin by covering organisms Gentamicin misses (some gram-positives, anaerobes, Candida), making this truly broad-spectrum.
  4. Limit to 2-4 weeks - the clobetasol 0.05% component is a Class I super-potent steroid and carries significant risks with prolonged use.
  5. Resistance concern - overuse of this combination (especially the antibiotic gentamicin) contributes to antimicrobial resistance.
  6. Do not apply on face, axillae, groin routinely - enhanced absorption in these areas multiplies adverse effects.
  7. Confirm the diagnosis first - if the underlying condition is viral (herpes) or purely inflammatory without infection, this combination is inappropriate and may worsen the condition.

Sources: Fitzpatrick's Dermatology (Vol. 1-2), Katzung's Basic & Clinical Pharmacology 16e, Andrews' Diseases of the Skin, Goodman & Gilman's Pharmacological Basis of Therapeutics, Jawetz Microbiology 28e, 1mg/Truemeds verified drug databases.
This is a shared conversation. Sign in to Orris to start your own chat.